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Studies have shown that ultrasound, used either alone or in combination with microbubble con-
trast agents, can increase cell membrane permeability to plasmid DNA. Because ultrasound is a
non-painful and well-established tool in clinical medicine, its potential to enhance DNA uptake
into the muscles of patients with muscular dystrophy is conceptually attractive. Therefore, we
evaluated the ability of ultrasound pulses (1 MHz; 1.5 W/cm2) to increase exogenous (LacZ) gene
expression in normal wild-type and dystrophic Dmdmdx/mdx mice after plasmid DNA injection into
muscle. We also ascertained whether co-injection of lipid-encapsulated perfluoropropane
microbubbles (Definity) or pretreatment with hyaluronidase could further increase the level of
gene transfer to ultrasound-treated muscles. The use of ultrasound did not increase transfection
efficiency in normal mice. In contrast, dystrophic mice demonstrated an increase in the number
of transfected fibers (threefold) as well as the amount of LacZ protein (22-fold) after ultrasound
exposure, provided that Definity was also co-injected with the DNA. Pretreatment of muscles with
hyaluronidase before ultrasound exposure was not effective in augmenting the level of gene trans-
fer. Under the optimal conditions for dystrophic muscle transfection (ultrasound + Definity),
there was no associated increase in muscle damage. Hence ultrasound may provide a safe and
effective method for enhancing gene transfer to dystrophic muscles, thereby increasing the
prospects for therapeutic application of naked DNA in muscular dystrophy patients.
Key Words: sonoporation, naked DNA, myofiber transfection, ultrasound contrast agents,
microbubbles, mdx mouse, Duchenne muscular dystrophyINTRODUCTION
Muscular dystrophies are a heterogeneous group of dis-
eases that may be associated not only with substantial
morbidity, but also with early mortality due to respira-
tory and cardiac muscle involvement. Advances in
molecular biology over the past several years have per-
mitted the identification of several defective genes under-
lying these disorders. Chief among these are defects of
the gene encoding dystrophin, a subsarcolemmal
cytoskeletal protein which has an important role in
maintaining the physical integrity of the muscle cell sur-
face membrane [1]. Lack of the dystrophin protein leads
to Duchenne muscular dystrophy (DMD), a relatively
common (1 in 3500 live male births) and ultimately fatal
X-linked form of muscular dystrophy. At the present
time, treatment for the disease is largely supportive.
Given the lack of effective treatment options, there hasMOLECULAR THERAPY Vol. 6, No. 5, November 2002
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therapy to DMD patients.
Since the original report by Wolff and colleagues [2]
that exogenous gene expression can be achieved in vivo
after direct intramuscular injection of plasmid DNA, there
has been great interest in the potential applicability of this
procedure to the treatment of muscular dystrophy.
Plasmid DNA injection has been shown to produce gene
transfer not only in appendicular muscles, but also in mus-
cles that are critical for survival such as the heart [3] and
diaphragm [4,5]. However, a major limitation to this
approach has been the fact that transfection efficiency is
generally very low [2,6].
Several studies have shown that ultrasound, used either
alone or in combination with ultrasound contrast agents,
can increase cell membrane permeability to macromole-
cules such as plasmid DNA [7–10]. This phenomenon has687
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f our study was tobeen referred to as sonoporation [7].
Most sonoporation studies have
been carried out on cultured cells
[7–10] or tumors in vivo [11–14], and
very little is known about the effects
of ultrasound on direct gene trans-
fer to skeletal muscle in vivo. In
addition, to our knowledge there
has been no previous investigation
of whether ultrasound is able to
enhance plasmid-mediated gene
transfer to dystrophic muscles.
Therefore, the global objective o
FIG. 1. Quantitation of -gal-expressing fibers
after LacZ plasmid DNA administration to the
tibialis anterior muscles of wild-type (A) and dys-
trophic (B) mice. The total number of -gal-
expressing fibers on the entire muscle cross sec-
tion was determined 5 days after DNA injection
in the absence (open bars) or presence (filled
bars) of ultrasound. Data are mean values ± SE.
*P < 0.05, within group comparison to no ultra-
sound. +P < 0.05, across group comparison to
plasmid alone. ‡P < 0.05, across group com-
parison to plasmid + Definity.investigate the potential usefulness of ultrasound as a
method for improving the efficiency of plasmid-mediated
gene transfer to skeletal muscle in general, and to dys-
trophic muscles in particular. In this study we used the
Dmdmdx/mdx mouse (hereafter referred to simply as mdx), an
animal model of DMD lacking dystrophin due to a point
mutation in the gene [15], in order to evaluate the
response to ultrasound in dystrophic muscles. Our spe-
cific aims were as follows: 1) to determine effects of ultra-
sound application on gene transfer efficiency after plasmid
DNA injection into normal and dystrophic muscles in vivo;
2) to evaluate the ability of adjuvant compounds, such as
a lipid-based microbubble ultrasound contrast agent or the
extracellular matrix-degrading enzyme hyaluronidase, to
enhance ultrasound-mediated effects on gene transfer; and
3) to ascertain whether the use of ultrasound to augment
plasmid-mediated gene transfer is associated with muscle
damage in either normal or dystrophic muscles.
RESULTS
To evaluate the effects of ultrasound on skeletal muscle
transfection efficiency, tibialis anterior muscles of wild-
type and dystrophic mice were injected with 25 g of plas-
mid and euthanized 5 days later. The effects of ultrasound
on expression of the lacZ gene product -galactosidase (-
gal) were determined under three different experimental
conditions: 1) use of plasmid alone; 2) use of plasmid +
Definity; and 3) use of plasmid + hyaluronidase pretreat-
ment. Figure 1 shows the mean number of muscle fibers688A Bexpressing -gal in all groups, whereas Fig. 2 shows levels
of -gal protein in the corresponding whole muscle
homogenates.
In wild-type C57BL10 mice (Fig. 1A), application of
ultrasound had no significant effect on the number of β-
gal-expressing muscle fibers after injection of plasmid
alone. Similarly, use of Definity as an adjuvant agent did
not significantly increase the efficacy of ultrasound treat-
ment in wild-type mice. On the other hand, ultrasound
did increase the number of transfected fibers in
hyaluronidase pretreated muscles, although the overall
level of transfection was significantly lower than in mus-
cles not subjected to hyaluronidase. In addition, it is inter-
esting to note that use of Definity on its own (that is, with-
out ultrasound) was associated with a statistically
significant increase in the number of transfected fibers in
wild-type mice.
A very different picture emerged in dystrophic muscle
(Fig. 1B). Neither Definity nor ultrasound on their own
had any significant effects on the number of transfected
fibers. However, when Definity and ultrasound were
applied in combination, there was a substantial increase
(approximately threefold) in the number of transfected
myofibers compared with plasmid alone without ultra-
sound. In addition, a significant effect of ultrasound on
transfection efficiency was also seen in muscles subjected
to hyaluronidase pretreatment. However, as was the case
in wild-type mice, the absolute number of transfected
myofibers found after hyaluronidase pretreatment in dys-
trophic mice was not superior to that obtained in muscles
injected with plasmid alone.MOLECULAR THERAPY Vol. 6, No. 5, November 2002
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in whole muscle homogenates were generally consistent
with the above morphometric data. Application of ultra-
sound to muscles of normal wild-type mice had no sig-
nificant effects on -gal protein expression under any of
the conditions studied (Fig. 2A). However, a small but sig-
nificant effect of Definity by itself was observed once again
in C57BL10 (but not dystrophic) mice.
In dystrophic mice, ultrasound significantly increased
the magnitude of -gal expression in the plasmid alone as
well as the plasmid + Definity groups, with a similar trend
also being found in the hyaluronidase pretreatment group
(Fig. 2B). The highest level of -gal protein expression was
found in the plasmid + Definity group treated with ultra-
sound, which increased approximately 22-fold compared
with plasmid alone without ultrasound. Thus, the relative
increase in -gal protein levels after ultrasound exceeded
the corresponding changes in transfected fiber number,
suggesting that the level of -gal expression per fiber was
also increased. This is supported by the representative
examples of -gal staining provided in Fig. 3, which show
that not only the number, but also the intensity, of -gal
staining was increased in ultrasound-treated muscles
receiving plasmid + Definity.
Because the highest transfection efficiency was obtained
in muscles receiving plasmid + Definity, potential tissue
damage related to the application of ultrasound was evalu-
ated under these conditions and compared with plasmid
alone (Fig. 4). As expected, the baseline level of muscle dam-
age was higher in dystrophic mice than in wild-type ani-
mals. However, use of ultrasound did not increase the mag-
nitude of muscle damage in wild-type or dystrophic muscles
injected with either plasmid alone or plasmid + Definity.MOLECULAR THERAPY Vol. 6, No. 5, November 2002
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Here we have explored the potential of
muscle-directed ultrasound to improve
transfection efficiency of intramuscularly
injected plasmid DNA in dystrophic as
well as normal muscles. The principal
findings of our study were as follows: 1)
significant ultrasound-mediated enhance-
ment of gene transfer by plasmid DNA
ystrophic muscles, but not in the muscles
FIG. 2. Level of -gal expression in muscle homogenates
from the tibialis anterior muscles of wild-type (A) and
dystrophic (B) mice. -Gal activity was determined 5 days
after DNA injection in the absence (open bars) or pres-
ence (filled bars) of ultrasound. Data are mean values ±
SE. *P < 0.05, within group comparison to no ultrasound.
+P < 0.05, across group comparison to plasmid alone. 
‡P < 0.05, across group comparison to plasmid + Definity.was found in d
of normal wild-type mice; 2) the beneficial effects of ultra-
sound on gene transfer in dystrophic muscles were largely
dependent upon the concomitant use of a microbubble
ultrasound contrast agent (Definity), whereas the combi-
nation of ultrasound and pretreatment of muscles with
the extracellular matrix-degrading enzyme hyaluronidase
was not effective; and 3) the use of ultrasound (either with
or without Definity) to increase gene transfer efficiency
was not associated with increased muscle damage.
Possible Mechanisms Underlying Ultrasound Effects
Although there is some evidence supporting a role for
receptor-mediated uptake of naked DNA by cells [16], the
actual mechanism of plasmid uptake by myofibers after
direct injection in vivo remains uncertain. Moreover, phys-
ical methods which are not expected to involve a recep-
tor-mediated mechanism can modify transfection effi-
ciency. For example, electroporation greatly increases in
vivo transfection efficiency when applied shortly after
direct intramuscular injection of naked DNA [17–19].
Unfortunately, this procedure is also associated with a sub-
stantial degree of muscle damage [18,19].
In the present study, we hypothesized that application
of ultrasound could have beneficial effects on in vivo trans-
fection by plasmid DNA without inducing significant mus-
cle damage. Several studies have shown that ultrasound
can be used to enhance cellular transfection, both in vitro
[7–10] and in vivo [11–14,20]. In principal, such ultrasound
effects could be exerted at a number of different levels
including plasmid DNA entry into the cell, intracellular
trafficking, and enhanced transcriptional as well as trans-
lational activity. However, it is likely that at least one689
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FIG. 3. Representative photomi-
crographs of histochemical stain-
ing for -gal in the dystrophic
mouse tibialis anterior muscle for
the following experimental
groups: (A) plasmid alone with-
out ultrasound; (B) plasmid alone
with ultrasound; (C) plasmid +
Definity with ultrasound; and (D)
plasmid + hyaluronidase with
ultrasound. Note that in addition
to an increase in the number of 
-gal expressing fibers, the inten-
sity of staining per fiber is
increased in (C).mechanism is via transient pore formation within the cell
membrane, a process termed sonoporation [7]. Indeed,
such pore formation [20,21], as well as entry of high
molecular weight dextrans [7] into cells after application
of ultrasound, has been well documented.
Acoustic cavitation, which is defined by the presence
of gas microbubbles that have been set into motion by
exposure to an acoustic field, seems to be the primary
mechanism underlying increases in cell membrane per-
meability and DNA delivery into cells after exposure to
ultrasound [7,10,22,23]. The microbubbles may be formed
intrinsically by the advancing acoustic waves (particularly
in tissues with high levels of dissolved gases) or may be
supplied exogenously as in the present study (that is,
Definity). Cell membranes can be permeabilized by several
cavitation-related phenomena. These include mechanical
forces exerted by oscillating bubbles or microstreaming;
liquid jets or shock waves following unstable or transient
cavitation, in which the bubbles grow and then collapse
violently; and the release of free radicals during the final
stages of bubble growth and collapse [10,23,24].
An important finding in the present investigation was
the differential susceptibility of normal and dystrophin-
deficient muscles to ultrasound-mediated effects on trans-
fection efficiency. This may reflect a greater susceptibility
of dystrophin-deficient myofibers to the effects of acoustic
cavitation on the muscle cell membrane. Indeed, it is well
established that muscle cells lacking dystrophin have690altered mechanical properties. This is manifested by an
increased vulnerability to hypo-osmotic shock [25] and
reduced membrane stiffness in vitro [26], as well as an
increased susceptibility to sarcolemmal disruptions trig-
gered by forceful muscle contractions in vivo [27,28].
Muscle cells lacking dystrophin are also reportedly more
vulnerable to oxidative stress [29]. Therefore, to the extent
that acoustic cavitation can create both mechanical and
oxidative stresses [24], it is perhaps not surprising that
muscles lacking dystrophin respond differently from nor-
mal muscles to the application of ultrasound pulses.
Moreover, additional factors such as the presence of regen-
erating myofibers within dystrophic muscles may also
have a role in the greater transfection efficiency found in
dystrophin-deficient muscles exposed to ultrasound.
Enhancement of Ultrasound Effects by Definity
Injection of microbubble-containing ultrasound contrast
agents can greatly increase cavitation effects on cells dur-
ing ultrasound exposure [7,23]. Such contrast agents are
approved for human use and consist of different types of sta-
bilized microbubbles surrounded by protein, sugar, or lipid
shells [23,30,31]. In the present study, we used Definity, an
injectable form of lipid-encapsulated perfluoropropane
microbubbles. The use of a lipid-based compound in this
study was considered as a potential advantage, as it might
allow the effects of liposomal and ultrasound-mediated
transfection to be combined. Such has been shown to be theMOLECULAR THERAPY Vol. 6, No. 5, November 2002
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what from those ofcase in several different cell types in
vitro [22,32], as well as in mouse tumor
models studied in vivo [12].
We found that while ultrasound
did not augment transfection effi-
ciency in normal muscles, use of
Definity on its own produced a sig-
nificant increase in both β-gal protein
levels and the number of transfected
fibers. On the other hand, use of
Definity in isolation had no signifi-
cant effects in dystrophic mice, but
was essential for allowing ultrasound-
induced enhancement of transfection
in this group. These results differ some
FIG. 4. Level of muscle damage and inflammation
in wild-type (A) and dystrophic (B) mouse muscles
at 5 days after DNA injection in the absence (open
bars) or presence (filled bars) of ultrasound. There
was no significant effect of ultrasound (with or
without concomitant use of Definity) on the level
of muscle damage in either mouse strain. Data are
mean values ± SE.Taniyama et al. [20], who recently reported an increased
transfection efficiency of normal rat muscles exposed to
ultrasound after plasmid DNA injection. The different
responses of normal muscles to ultrasound observed in
our study are likely related to methodological factors such
as the use of different ultrasound parameters and
microbubble contrast agents, as well as the different ani-
mal species used. However, similar to our findings in dys-
trophic mice, these authors found that use of an albumin-
encapsulated microbubble contrast agent (Optison) was
needed to achieve significant effects [20].
Lack of Increased Muscle Damage after Ultrasound
Injection of plasmid DNA into muscle is known to cause
mild inflammation, which has been linked to the pres-
ence of proinflammatory unmethylated CpG motifs
within prokaryotic DNA [33,34]. Consistent with previous
reports by other investigators [35], we also observed a mild
degree of interstitial inflammation 5 days after plasmid
DNA injection. This occurred in the absence of ultrasound
exposure and amounted to approximately 5% of cross-sec-
tional area in normal muscles. However, it is important to
note that ultrasound itself was not associated with any
further increase in muscle damage or inflammation.
Maximizing transfection efficiency depends on increas-
ing membrane porosity while avoiding irreversible cellular
damage. It is known that breaches of the cell surface mem-
brane of muscle fibers can be resealed and thus allow necro-
sis to be avoided [36,37]. In addition, to the extent that the
influx of inflammatory cells associated with muscle damage
boosts the host immune response against transgene-MOLECULAR THERAPY Vol. 6, No. 5, November 2002
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lower immunogenicity. Hence the absence of increased
damage with ultrasound in our study not only increases the
clinical acceptability of this intervention, but it may also
allow for more sustained transgene expression over time.
In contrast, application of in vivo electroporation pro-
duces muscle injury and inflammation, with one-third to
one-half of the muscle cross-sectional area showing damage
in some studies [18,19]. The propensity of in vivo electropo-
ration to cause muscle damage likely accounts for the obser-
vation that transfection efficiency is approximately 50%
lower in mdx mice than in normal wild-type mice [39]. This
suggests a greater vulnerability to electroporation-induced
damage in dystrophin-deficient fibers, which would help
explain the reduced level of transgene expression [39]. The
results of our study suggest that ultrasound may be better
able to achieve the optimal balance between membrane pore
formation and resealing in dystrophic muscles.
Implications for Gene Therapy of Muscular
Dystrophy
An important and still unresolved issue for gene therapy
of DMD is the most appropriate choice of vector. Thus far,
most research in this area has involved viral vectors.
Although the latter are highly efficient gene transfer vehi-
cles in muscle, a significant disadvantage of virus-based
systems is the host immune response elicited by these vec-
tors [38,40,41]. This has raised important safety concerns,
and also triggers neutralizing antibodies against viral pro-
teins that can prevent effective readministration [42,43].
Stimulation of cytotoxic T-cell responses may also occur,
and this leads to the transduced muscle cell population691
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therapy [40–42]. In addition, not all viral vectors (for
example, adeno-associated virus) are able to accommodate
the full-length dystrophin gene. An alternative approach
is to use a nonviral vector such as plasmid DNA, which is
less toxic, cheaper, easier to prepare, and able to accom-
modate the full-length dystrophin cDNA. However, the
major drawback of the naked DNA approach up to now
has been the very low gene transfer efficiency compared
with viral vectors.
The use of ultrasound as an adjuvant measure to
enhance plasmid DNA delivery has a number of advanta-
geous features, which should increase the overall prospects
for therapeutic application of naked DNA in muscle. In
contrast to electroporation, ultrasound is a non-painful
and well-established tool in clinical medicine.
Furthermore, ultrasound is currently used to treat muscu-
loskeletal injuries in humans [44], and animal studies sug-
gest the potential for positive effects on muscle repair
processes [45,46]. Whereas electroporation is less effective
in dystrophic muscles [39], precisely the opposite pattern
was observed with ultrasound (that is, a greater efficacy of
ultrasound-induced transfection in mdx than in normal
mouse muscles). Equally important, there was no histo-
logical evidence of increased damage in dystrophic mus-
cles subjected to ultrasound. The non-invasive nature of
ultrasound and the absence of neutralizing antibodies
against plasmid DNA vectors also raise the possibility that
treatments could be easily repeated on a relatively frequent
basis, thereby permitting selected muscles to be progres-
sively “loaded” with therapeutic DNA in a step-wise fash-
ion. Lastly, ultrasound-mediated destruction of intravas-
cularly injected microbubble contrast agents has been used
to induce microvessel breaches that are large enough to
permit extravasation of macromolecules, including gene
transfer vectors [47,48]. Therefore, ultrasound could be a
powerful adjunct to intravascular as well as intramuscular
delivery of plasmid DNA to dystrophic muscles. Further
studies will be required to investigate the full therapeutic
potential of ultrasound-based approaches to gene delivery
in the setting of muscular dystrophy.
MATERIALS AND METHODS
Preparation of plasmid DNA. Plasmid DNA was produced according to
standard methods [5] and purified to remove contamination with endo-
toxin. The plasmid contained the LacZ cDNA, which was driven by a
chicken -actin promoter/cytomegalovirus enhancer construct [49]. All
experimental groups were injected with a single pooled sample of plasmid
DNA in order to eliminate any potential variation caused by the use of dif-
ferent DNA preparations.
Animal procedures. Dystrophic mdx and normal wild-type (C57BL10) mice
were purchased from The Jackson Laboratory (Bar Harbor, ME). The mice
were provided with food and water ad libitum. Before intramuscular injec-
tion of plasmid DNA, the mice were anesthetized with ketamine (130
mg/kg) and xylazine (20 mg/kg). Mice were euthanized by anesthetic over-
dose. All experimental protocols were approved by the institutional ani-
mal care and ethics committee.692Animals were studied at 8–10 weeks of age. Tibialis anterior (TA) mus-
cles of both hindlimbs were initially injected with plasmid DNA (25 µg).
One TA muscle was exposed to ultrasound treatment immediately after
plasmid administration, whereas the opposite TA muscle served as a within-
animal control. A commercially available sonicator (Ultramax Excel, Excel
Tech Ltd, Oakville, Ontario) was used to transcutaneously deliver ultra-
sound pulses of 3 ms duration at 1 MHz frequency and 1.5 W/cm2 inten-
sity, with an inter-pulse interval of 7 ms (30% duty cycle). These settings
were selected to promote gene transfer while minimizing tissue injury
related to thermal effects of ultrasound [45]. Ultrasound gel (EcoLotion,
Eco-Med Pharmaceuticals Inc., Mississauga, Ontario) was used as a coupling
agent, and the ultrasound head was held in a stationary position over the
TA muscle during the entire treatment period of 2 minutes.
Pre-injection of microbubble ultrasound contrast agents has been
shown to increase the permeabilizing effects of ultrasound on cells
[20,23,30,31]. In addition, pretreatment of skeletal muscles with the extra-
cellular matrix-degrading enzyme hyaluronidase increases the efficiency of
plasmid-mediated gene transfer by in vivo electroporation [19]. Therefore,
we also evaluated the ability of such adjuvant measures to increase gene
transfer efficiency after ultrasound treatment of normal and dystrophic
muscles. The ultrasound contrast agent Definity (Bristol-Myers Squibb
Canada, Inc., Saint-Laurent, Quebec), a formulation of lipid-encapsulated
perfluoropropane microbubbles, was mixed with the plasmid DNA (16.5
l of Definity in a total injectate volume of 50 l) by vortexing for 30 sec-
onds immediately before intramuscular injection. Before mixing of the
DNA with Definity, the latter was rapidly agitated using a mechanical vial
shaker supplied by the manufacturer. Because the physical properties of
Definity can be altered by passage through a small diameter needle, a 20-
gauge needle was used (as suggested by the manufacturer) for most plas-
mid injections. However, for hyaluronidase pretreatment experiments (25
l of 400 U/ml injected two hours before plasmid DNA delivery [19]), a 27-
gauge needle was used for plasmid DNA injection of the muscles.
Detection of transgene expression by chemiluminescence. Quantitation of
the lacZ gene product, -gal, was performed on tissue homogenates using
a commercially available kit (Galacto-Light, Tropix, Inc., Bedford, MA).
Each muscle sample was blotted dry and weighed before freezing in liquid
nitrogen. It was then pulverized into a powder, suspended in 200 l of lysis
solution and homogenized. The homogenate was assayed for -gal activ-
ity by chemiluminescence according to the manufacturer’s instructions. A
standard curve was carried out using commercially available -gal protein
(Boehringer Mannheim, Laval, Quebec). Values for -gal expression were
normalized to total protein within the sample.
Morphometric quantification of gene transfer efficiency and muscle dam-
age. Muscle sections (10 m) were fixed in 1.5% glutaraldehyde in PBS for
3 minutes and then rinsed with PBS at room temperature. Sections were
stained overnight for -gal activity by incubation at 37C with 400 g/ml
X-gal, 1 mM MgCl2, 5 mM potassium ferrocyanide, and 5 mM ferricyanide
in PBS. Microscopically visualized sections were photographed using a dig-
ital camera and the image was stored on a computer. Analysis of the num-
ber of individual muscle fibers was performed by manual tag using a com-
mercial software package (Image-Pro Plus, Media Cybernetics, Silver Springs,
MD). Fiber counts were performed from cross-sections exhibiting the max-
imal number of blue fibers, irrespective of the intensity of blue staining.
To quantify muscle damage, muscle sections were stained with hema-
toxylin and eosin. The muscle section with the greatest amount of inflam-
matory cell infiltration was chosen for muscle damage evaluation. This
was done by determining the area fraction (expressed as a percentage) of
damage, which was calculated by dividing the sum of all areas containing
inflammatory cells and myofiber degeneration by the total area of the tis-
sue section [42].
Statistical analysis. All data were analyzed with a statistics software pack-
age (SigmaStat, Jandel Scientific, San Rafel, CA). Differences between ultra-
sound-treated and untreated groups were determined using Student’s two-
tailed t-test for independent samples. Differences within ultrasound-treated
or untreated groups were tested by one-way ANOVA, with post-hoc appli-
cation of the Tukey procedure where appropriate. Statistical significance
was defined as P < 0.05.MOLECULAR THERAPY Vol. 6, No. 5, November 2002
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